⌘K

Home/Filings/4/0001235802-21-000131

4//SEC Filing

Bandy Barton P. 4

Accession 0001235802-21-000131

CIK 0001427570other

View on SEC.gov Company Profile

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 4:18 PM ET

Size

4.7 KB

Accession

0001235802-21-000131

Insider Transaction Report

Form 4

Period: 2021-11-02

ReShape Lifesciences Inc.RSLS

Bandy Barton P.

DirectorPresident and CEO

Transactions

Sale
Common Stock, $0.001 par value per share
2021-11-02$2.69/sh−13,505$36,328→ 865,442 total

Footnotes (1)

[F1]These shares were sold to cover taxes in connection with the vesting of restricted stock units.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

ReShape Lifesciences Inc.

CIK 0001427570

Entity typeother

Related Parties

1

filerCIK 0001773309

Filing Metadata

Form type: 4
Filed: Nov 15, 7:00 PM ET
Accepted: Nov 16, 4:18 PM ET
Size: 4.7 KB

View on SEC.gov